Robot-Assisted Esophagectomy vs Conventional MIE: Annals of Surgical Oncology | April 2026

Introduction

Surgical management of Esophageal cancer continues to evolve, with minimally invasive techniques improving perioperative outcomes. A newer concept—total mesoesophageal excision (TME)—aims to enhance oncologic clearance. The integration of robotic surgery with TME (RATME) is proposed to further refine precision and outcomes compared to conventional minimally invasive esophagectomy (MIE).

Problem Statement

It remains unclear whether robot-assisted esophagectomy combined with TME offers meaningful advantages over conventional minimally invasive approaches in terms of surgical and oncologic outcomes.

Summary

This multicenter retrospective study compared robot-assisted TME esophagectomy (RATME) with other minimally invasive approaches. The robotic TME group had longer operative times but demonstrated important perioperative advantages, including reduced blood loss, shorter postoperative hospital stay, and lower complication rates.

Additionally, the TME approach resulted in a higher lymph node yield, suggesting improved oncologic clearance. Although overall survival and disease-free survival were not significantly different across groups, trends toward lower recurrence and mortality were observed in the RATME group.

The key takeaway is that robot-assisted TME appears to enhance surgical precision and short-term outcomes, with potential long-term benefits. However, the trade-off includes longer operative time, and further studies are needed to confirm survival advantages.

Key Takeaways: Better surgery today may translate into better cancer outcomes tomorrow—but stronger evidence is still needed.